RedHill Biopharma Ltd.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $166.4M | $180.2M | $29.3M |
| FY2021 | $172.3M | $181.2M | $29.5M |
| FY2022 | $207.3M | $158.9M | $20.0M |
| FY2023 | $21.0M | $23.0M | $5.6M |
| FY2024 | $22.7M | $18.0M | $4.6M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $166.4M | $180.2M | $29.3M |
| FY2021 | $172.3M | $181.2M | $29.5M |
| FY2022 | $207.3M | $158.9M | $20.0M |
| FY2023 | $21.0M | $23.0M | $5.6M |
| FY2024 | $22.7M | $18.0M | $4.6M |